Pharmaceutical Outsourcing - Executive Summary Q2 2019

Published on: 07/26/2019

Capstone Headwaters’ Q2 Pharmaceutical Outsourcing Executive Summary discusses the active M&A market in the industry, fueled by pressures faced by pharmaceutical companies to accelerate drug development and displace profit drops.  To learn more about the content of the report or Capstone Headwaters’ Healthcare practice, please reach out to Eric Williams.  Available for download below, the report includes:

  • Transaction Volume Breakdown
  • Novel Drug Approvals
  • Transaction Highlight
  • Firm Track Record

Key Contacts